Microarray Analysis of Gene Expression at the Tumor Front of Colon Cancer

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Tumor budding at the cancer tissue boundary is a key prognostic factor in colorectal cancer.
• Limited research exists on gene expression at the tumor front in clinical colon cancer samples.

Purpose of the Study:

• To investigate gene expression differences between the tumor front and tumor center in surgically resected colon cancer specimens.
• To identify molecular markers associated with colon cancer invasion at the tumor periphery.

Main Methods:

• Laser microdissection of tumor tissues from 20 surgically resected colon cancer specimens.
• Microarray analysis to compare gene expression between the tumor front and tumor center.
• Identification of significantly differentially expressed genes.

Main Results:

• Six chemokines (CCL2, CCL18, CXCL9-11, IL8) and two apoptosis-related molecules (UBD, BIRC3) were significantly upregulated at the tumor front.
• Elevated expression of laminin gamma 2 (LAMC2), matrix metallopeptidase 7 (MMP7), and epithelial-mesenchymal transition (EMT)-related molecules was observed at the tumor front.
• Chemokines exhibited larger fold changes compared to EMT-related molecules.

Conclusions:

• Chemokines, alongside EMT-related molecules, are implicated in the invasion process of colon cancer.
• The study highlights the potential of chemokines as therapeutic targets for inhibiting colon cancer spread.
• Gene expression analysis at the tumor front provides critical insights into colon cancer progression and metastasis.